Global Monofocal IOLs Market Strategic Research Report

Scope of the Report

The global Monofocal IOLs market size is predicted to grow from US$ 2,152 million in 2025 to US$ 3,401 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

Monofocal IOLs refer to intraocular lenses with a single fixed focal point, providing clear vision at only one distance after surgery. Patients typically choose to set them for clear distance vision, requiring glasses for intermediate and near tasks. From an industry perspective, this field encompasses three major product forms. Standard monofocal IOLs provide basic vision-restoring function. Enhanced monofocal IOLs offer better intermediate vision through improved optical design. Toric monofocal IOLs add cylindrical lens design to correct corneal astigmatism. Based on material, they are mainly divided into rigid PMMA lenses and foldable acrylic or silicone lenses, with foldable lenses becoming the market mainstream due to smaller incision size and faster recovery. In recent years, as cataract surgery has shifted from vision-restoring to refractive treatment, the utilization rate of premium functional IOLs such as multifocal and extended depth of focus lenses has continued to rise. However, monofocal IOLs remain the most fundamental and widely used product type in global cataract surgery, serving as the cornerstone of the intraocular lens market, owing to their excellent distance visual quality, absence of visual disturbances, and the highest cost-performance ratio.

Market Development Opportunities and Key Drivers

Global population aging is accelerating, with the number of cataract patients continuing to rise. China alone had over 147 million cataract patients in 2024, with approximately 4.609 million surgeries performed. The centralized volume-based procurement of high-value medical consumables has included monofocal IOLs in its catalog, reducing the price of non-toric monofocal IOLs from 2,500 yuan to nearly 800 yuan, an average price reduction of 60 percent, significantly improving product accessibility. The localization rate for monofocal IOLs has reached as high as 32 percent, with domestic brands such as Eyecare Medical holding notable advantages in this segment. Enhanced monofocal IOLs, as a new category positioned between standard monofocal and EDOF lenses, enhance intermediate vision while maintaining distance visual quality, offering a differentiated new option for the market.

Market Challenges and Risks

The market structure is accelerating its shift toward premium products. The domestic utilization rate of monofocal IOLs was approximately 70 percent in 2025, while the share of multifocal, EDOF, and other products has risen to about 30 percent and is expected to expand further. Refractive lenses such as trifocal and EDOF IOLs have received dense regulatory approvals, with nine new products approved between 2024 and 2025. Large ophthalmology chains are actively promoting refractive cataract surgery as a high-value service, and multinational giants including Alcon and Johnson & Johnson are accelerating their deployment in premium product lines. Quality and safety issues cannot be ignored. In April 2025, the importation, distribution, and use of monofocal IOLs from Indonesia's Rohto Laboratories were suspended by the National Medical Products Administration due to serious deficiencies in its quality management system, and its eligibility for centralized procurement was also revoked.

Downstream Demand Trends

The price reduction of monofocal IOLs through centralized procurement has made their cost-performance advantage prominent, positioning them as the mainstream product for vision-restoring cataract surgery in public hospitals. For patients with fundus diseases, glaucoma, or other conditions unsuitable for premium IOL implantation, monofocal IOLs remain the safest and most reliable choice due to the absence of visual disturbances such as glare and halos. Enhanced monofocal IOLs have demonstrated differentiated advantages, with studies showing they provide better intermediate vision while achieving similar visual function improvement to standard monofocal IOLs in glaucoma patients, making them a promising alternative for patients with concurrent glaucoma and cataracts. Approximately 80 percent of individuals over 60 have both presbyopia and cataracts, with some patients still choosing monofocal IOLs combined with spectacles due to financial or ocular condition limitations.

Regional Trends

North America, supported by mature reimbursement policies for intraocular lenses and strong demand for customized lenses, held a 33.85 percent share of the global intraocular lens market in 2023, with monofocal IOLs as a basic product enjoying stable replacement demand. European market demand for monofocal IOLs remains relatively stable, and PMMA lenses continue to maintain a strong market position in Europe. China and the broader Asia-Pacific region are the core growth engines for global monofocal IOLs. The Chinese intraocular lens market grew by 6.2 percent year-on-year in 2024, with monofocal lenses accounting for approximately 53 percent of the market share. The proportion of cataract surgeries performed in private hospitals in China has continued to rise, approaching nearly 30 percent in 2024. Domestic brands including Eyecare Medical and Haohai Biological have demonstrated the ability to compete with imported brands in the monofocal segmen

Key Questions Addressed in this Report

What is the 10-year outlook for the global Monofocal IOLs market?

What factors are driving Monofocal IOLs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Monofocal IOLs market opportunities vary by end market size?

How does Monofocal IOLs break out by Type, by Application?

This report presents a comprehensive overview of the global Monofocal IOLs market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Standard Monofocal IOL
• Enhanced Monofocal IOL
• Toric Monofocal IOL

Segment by Curvature Design

• Aspheric Monofocal IOLs
• Spheric Monofocal IOLs

Segment by Material

• Silicone Type
• Acrylic Type
• Polymethyl Methacrylate Type

Segment by Application

• Cataract Surgery
• Refractive Lens Exchange

Segment by Application

• Manual Implantation Type
• Preloaded System Type

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Monofocal IOLs market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Manual Implantation Type, Preloaded System Type evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact